What's Going On With Moderna Stock?
Portfolio Pulse from Ryan Gustafson
Moderna, Inc. (NASDAQ:MRNA) shares traded higher after the company signed a memorandum of understanding and land collaboration agreement to research, develop and manufacture mRNA medicines in China. The agreement allows Moderna to develop drugs exclusively for the Chinese market. The company also announced global regulatory submissions for mRNA-1345, including the European Medicines Agency.
July 05, 2023 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna's stock traded higher following the announcement of a collaboration agreement to develop mRNA medicines in China and global regulatory submissions for mRNA-1345.
The news of Moderna's collaboration agreement to develop mRNA medicines in China and the global regulatory submissions for mRNA-1345 is likely to be viewed positively by investors, leading to an increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100